Overview / Abstract: |
Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit. Learning Objectives - Evaluate current clinical evidence on precision medicine |
Expiration |
Jan 26, 2019 |
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.Penn State College of Medicine designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Paul G. Richardson, MD—Program Co-Chair A. Keith Stewart, MBChB, MRCP, FRCPC, MBA—Program Co-Chair Jesus G. Berdeja, MD Nina Shah, MD Peter Voorhees, MD Katja Weisel, MD |
Activity Specialities / Related Topics |
Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy |
Sponsors / Supporters / Grant Providers |
Support for this activity has been provided through educational grants from Amgen and Celgene Corporation. |
Keywords / Search Terms |
RedMedEd RedMedEd MMRF, MM, multiple myeloma, multiple myeloma research foundation, outcomes, disease, treatment, evidence, precision medicine, risk stratification, imaging, combinations, frontline, induction therapy, maintenance therapy, therapy, refractory, Free CME, hematollogist-oncologist, medical oncologist, free, CME Free CE CME |